Viewing Study NCT02479412


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2026-03-08 @ 11:00 PM
Study NCT ID: NCT02479412
Status: COMPLETED
Last Update Posted: 2018-02-15
First Post: 2015-06-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
None Efficacy View
None Safety View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mild to moderate asthma View
None FEV1 View
None efficacy View
None safety View